S
NVRO

SignatureFD’s NEVRO CORP. NVRO Stock Holding History

SignatureFD’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-184
Closed -$1.55K – 3329
2024
Q2 		$1.55K Buy
184
+64
+53% +$682 ﹤0.01% 2820
2024
Q1 		$1.73K Buy
120
+40
+50% +$661 ﹤0.01% 2839
2023
Q4 		$1.72K Sell
80
-64
-44% -$1.14K ﹤0.01% 2801
2023
Q3 		$2.77K Buy
144
+82
+132% +$1.75K ﹤0.01% 2689
2023
Q2 		$1.58K Sell
62
-40
-39% -$1.16K ﹤0.01% 2874
2023
Q1 		$3.69K Buy
102
+66
+183% +$2.32K ﹤0.01% 2621
2022
Q4 		$1.43K Sell
36
-236
-87% -$9.81K ﹤0.01% 2896
2022
Q3 		$13K Buy
272
+191
+236% +$8.86K ﹤0.01% 1965
2022
Q2 		$4K Sell
81
-45
-36% -$2.47K ﹤0.01% 2564
2022
Q1 		$9K Sell
126
-373
-75% -$26.9K ﹤0.01% 2228
2021
Q4 		$40K Buy
499
+492
+7,029% +$49.3K ﹤0.01% 1436
2021
Q3 		$1K Sell
7
-4
-36% -$524 ﹤0.01% 2957
2021
Q2 		$2K Buy
+11
New +$1.72K ﹤0.01% 2635
2020
Q4 		– Sell
-5
Closed -$1K – 2732
2020
Q3 		$1K Buy
+5
New +$668 ﹤0.01% 2527
2016
Q4 		– Sell
-74
Closed -$8K – 1283
2016
Q3 		$8K Buy
+74
New +$6.68K ﹤0.01% 1105

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

SignatureFD's NVRO Position: Q3 2024 in Review

SignatureFD sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 184 shares — an estimated $1.55K sold.

SignatureFD first reported a position in NVRO in Q3 2016 and held it in 15 quarters. The position peaked at $40K in Q4 2021. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • SignatureFD reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • SignatureFD sold 184 NEVRO CORP. shares in Q3 2024, an estimated $1.55K.
  • SignatureFD first reported a position in NEVRO CORP. in Q3 2016 and held it in 15 quarters.
  • SignatureFD's NEVRO CORP. position peaked at $40K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on SignatureFD's 13F filing for Q3 2024, filed 21 Oct 2024.